Studies have shown that JAK1 inhibitors can alleviate RA pain caused by both inflammatory and non-inflammatory mechanisms, and various cytokines directly or indirectly regulated by the JAK/STAT pathway play a crucial role in the various mechanisms mediating RA pain (61). This evidence concerns the gene SOAT1 and rheumatoid arthritis.